| Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study | |
| Li, Jin; Xu, Ruihua; Qin, Shukui; Liu, Tianshu; Pan, Hongming; Xu, Jianming; Bi, Feng; Lim, Robert; Zhang, Suzhan; Ba, Yi | |
| 刊名 | FUTURE ONCOLOGY
 |
| 2018 | |
| 卷号 | 14期号:20 |
| 关键词 | aflibercept Asia-Pacific FOLFIRI mCRC oxaliplatin-pretreated |
| ISSN号 | 1479-6694 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3609544 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Li, Jin,Xu, Ruihua,Qin, Shukui,et al. Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study[J]. FUTURE ONCOLOGY,2018,14(20). |
| APA | Li, Jin.,Xu, Ruihua.,Qin, Shukui.,Liu, Tianshu.,Pan, Hongming.,...&Shen, Lin.(2018).Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study.FUTURE ONCOLOGY,14(20). |
| MLA | Li, Jin,et al."Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study".FUTURE ONCOLOGY 14.20(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论